Myeloid Cells TREM Down Anti-tumor Responses

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Tumor-associated myeloid cells often create an immunosuppressive tumor microenvironment.
• TREM2 (triggering receptor expressed myeloid 2) is implicated in myeloid cell function within tumors.

Purpose of the Study:

• To investigate the role of TREM2 in modulating the immunosuppressive properties of tumor-associated myeloid cells.
• To evaluate the therapeutic potential of combining TREM2 blockade with immune-checkpoint therapy.

Main Methods:

• Analysis of TREM2's function in tumor-associated myeloid cells.
• Experimental models combining TREM2 blockade with immune-checkpoint inhibitors.

Main Results:

• TREM2 blockade alters the immunosuppressive profile of tumor-associated myeloid cells.
• Combined therapy with TREM2 blockade and immune-checkpoint therapy resulted in enhanced anti-tumor immune responses.
• This combination therapy led to a significant reduction in tumor growth.

Conclusions:

• TREM2 plays a critical role in establishing an immunosuppressive tumor microenvironment.
• Targeting TREM2 in combination with immune-checkpoint therapy represents a promising strategy for cancer treatment.